Cardiac disorders and stroke

Current Opinion in Neurology

Volumn 11, Issue 1, 1998, Pages 51-56

  Sen, Souvik ^a   Oppenheimer, Stephen M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AORTA ATHEROSCLEROSIS; ATHEROMA; BRAIN EMBOLISM; CAROTID ARTERY OBSTRUCTION; CAUSE OF DEATH; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART INFARCTION; HUMAN; INCIDENCE; PERIOPERATIVE PERIOD; REVIEW; RISK FACTOR; STROKE; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANIMALS; CEREBROVASCULAR DISORDERS; HEART; HEART DISEASES; HUMANS;

EID: 0031972955     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199802000-00009     Document Type: Review

References (45)

1. Streifler JY, Katz M. Cardiogenic cerebral emboli: diagnosis and treatment. Curr Opin Neurol 1995; 8:45-54.
2. Hertzer NR, Young JR, Beven EG, Graor RA, O'Hara PJ, Ruschhaupt WF III, et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Int Med 1985; 145:849-852.
3. Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD. Frequency and severity of asymptomatic coronary artery disease in patients with different causes of stroke. Stroke 1997; 28:941-945. A prospective study in which 69 patients with stroke or transient ischemic attack were evaluated with cardiac stress test to assess for CAD. Twenty-four out of 69 (35%) patients were noted to have asymptomatic CAD. Large artery cerebrovascular disease, smoking, veteran status, and possibly left ventricular hypertrophy were predictive of asymptomatic CAD on the multivariate analysis.
4. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. New Engl J Med 1991; 325:445-453.
5. Oppenheimer SM. Neurogenic cardiac effects of cerebrovascular disease. Curr Opin Neurol 1994; 7:20-24.
6. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologie assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology 1978; 28:973-977.
7. Kaarisalo MM, Immonen-Raiha P, Marttila RJ, Veikko S, Kaarsalo E, Salmi K, et al. Atrial fibrillation and stroke: mortality and causes of death after the first acute ischemic stroke. Stroke 1997; 28:311-315.
8. Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1000 consecutive patients: a contrast transesophageal echocardiography study. Chest 1995; 107:1504-1509.
9. Salasidis GC, Latter DA, Steinmetz OK, Blair J, Graham AM. Carotid duplex scanning in preoperative assessment for coronary artery revascularization: the association between peripheral vascular disease, carotid artery stenosis, and stroke. J Vasc Surg 1995; 21:154-162.
10. Oppenheimer SM, Martin WM, Kedem G. Lett insular cortex lesions perturb cardiac autonomic tone. Clin Autonomie Res 1996, 6:131-140. A prospective clinical study in which seven patients with confirmed infarct (on magnetic resonance imaging) in the left insular cortex were investigated with computerized autonomie platform monitoring, followed by power spectral analysis to assess the cardiac autonomie tone. The results suggest that the left insular lesion may shift the autonomic balance towards increased sympathetic tone and decreased parasympathetic tone. Such a change has been shown to predispose to cardiac dysrrhythmia.
11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. Arch Intern Med 1987; 147:1561-1564.
12. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke 1990; 21:4-13.
13. Shively BK, Geigland EA, Crawford MH. Regional left atrial stasis during atrial fibrillation and flutter. J Am Coll Cardiol 1996; 27:1722-1729. A prospective transesophageal pulse wave Doppler study which looked at the regional left atrial blood flow velocity in patients with atrial fibrillation or flutter and assessed their risk of stroke. A quantitative relationship was found between the risk of stroke and left atrial stasis (< 15 cms left atrial blood flow velocity).
14. Chimowitz MI, De Georgia MA, Poole RM, Hepner A, Armstrong WM. Left atrial spontaneous echo contrast highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993; 24:1015-1019.
15. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997; 29:106-112. A prospective study that looked at coagulation variables in patients during atrial fibrillation and 7 days postconversion to sinus rhythm. Beta-thromboglobulin, platelet factor 4, thrombin-antrthrombin III complex (markers of increased coagulation) positively correlated with the duration of atrial fibrillation.
16. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990; 21:47-51.
17. Kanter MC, Tegeler CH, Pearce LA, Weinberger J, Feinberg WM, Anderson DC, et al. Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. Arch Intern Med. 1994; 154:1372-1377.
18. Sandercock P, Bamford J, Dennis M, Burn J, Slattery J, Jones L, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influences on early and long term prognosis (Oxfordshire community stroke project). BMJ 1992; 305:1460-1465.
19. Laupacis A, Cuddy TE. Prognosis of patients with atrial fibrillation. Can J Cardiol 1991; 12 (Suppl A):14-16.
20. Chandelise L, Pinardi G, Morabito A. Mortality in acute stroke with atrial fibrillation. The Italian Acute Stroke Study Group. Stroke 1991; 22:169-174.
21. Boysen G. Anticoagulation for atrial fibrillation and stroke prevention. Neuroepidemiology 1993; 12:280-284.
22. EAFT (European Atrial Fibrillation Trial) Study Group: Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack of minor stroke. Lancet 1993, 342:1255-1262.
23. SPAF Investigators: Stroke prevention in atrial fibrillation study: final results. Circulation 1991, 84:527-539.
24. Miller VT, Rothrock JF, Pearce LA, Feinberg WM, Hart RG, Anderson DC. Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology 1993; 43:32-36.
25. Cowburn P, Cheland JGF. Clinical trial updates: SPAF-III results. Eur Heart J 1996; 17:1129. A brief clinical update which summarizes the risk stratification used to assign medical therapy (aspirin or warfarin) in patients with stroke and atrial fibrillation enrolled in the Stroke Prevention in Atrial Fibrillation III trial.
26. The NINDS Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM 1995; 333:1581-1587.
27. Bougusslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G, for the Lausanne Stroke Registry Group. Stroke recurrence in patients with patent foramen ovale. Neurology 1996; 46:1301-1305. A prospective study of 140 patients with stroke and PFO assessed by transesophageal echocardiogram followed for a mean period of 36 months. The rate of stroke or death was 2.4% whereas that for neurologic event (stroke or transient ischemic attack) was 3.8% per year. Using multivariate analysis the following factors were found to be predictive of stroke recurrence in PFO patients: interatrial communication, posterior cerebral artery stroke, coexisting cause of stroke and history of migraine.
28. The French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with PFO and ASA and cryptogenic stroke and TIA. Am Heart J 1995; 130:1083-1088.
29. Nendaz M, Sarasin FP, Bougusslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale: antigcoagulants, antiaggregants, foramen closure, or nothing? Eur Neurol 1997, 37:199-204. A review article on the benefits and risks of different therapeutic options currently available to prevent stroke recurrence in PFO patients. A comparison is made between oral anticoagulation and antiplatelet therapy, and more invasive procedures such as surgical or transcatheter closure of the defect. The risk of stroke recurrence in PFO patients is discussed.
30. Comess KA, de Rook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994; 23:1598-1603.
31. Petty GW, Khandheria BK, Chu C, Sicks JD, Whisnant JP. Patent foramen ovale in patients with cerebral infarction: a transesophageal echocardiographic study. Arch Neurol 1997; 54:819-822.
32. Levine MN, Raskob G, Landefeld CS, Hirsh J: Hemorrhagic complications of anticoagulant treatment. Fourth ACCP Consensus Conference on Anti-thrombotic Therapy. Chest 1995; 108 (Suppl):276S-290S.
33. Devuyst G, Bougusslavsky J, Ruchat P, Jeanrenaud X, Despland PA, Regli F, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial doppler ultrasound. Neurology 1996; 47:1162-1166. A prospective study in which 30 patients with stroke and PFO and no other apparent cause of stroke were subjected to surgical closure of PFO. No stroke recurrence was reported over a mean follow-up period of 23.4 months.
34. Homma S, Di Tullio MR, Sacco RL, Weslow RG, Kargman DE, Smith C, Mohr JP. Surgical closure of patent foramen ovale in selected patients with cryptogenic stroke: a preliminary experience [Abstract]. Stroke 1995, 26:172.
35. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent of foramen ovale after presumed paradoxical embolism. Circulation 1992; 86:1902-1908.
36. Trehan N, Mishra M, Dhole S, Mishra A, Karlekar A, Kohli VM. Significantly reduced incidence of stroke during coronary artery bypass grafting using transesophageal echocardiography. Eur J Cardiothor Surg 1997; 11:234-242. A prospective study in which 792 patients undergoing CABG were intraoperatively evaluated for aortic atherosclerosis by transesophageal echocardiogram. On the basis of the findings, appropriate modifications of surgical techniques were made. An overall perioperative stroke rate of 0.76% was reported. Age, diabetes, increased serum triglycerides and very low density lipoprotein, and aortic calcification were identified to be the risk factors for perioperative stroke on multivariate analysis.
37. Duda AM, Letwin LB, Suffer FP, Goldman SM. Does routine use of aortic ultrasonography decrease the stroke rate in coronary artery bypass surgery? J Vasc Surg 1995; 21:98-107.
38. Braekken SK, Russel D, Brucher R, Abdelnoor M, Svennevig JL. Cerebral microemboli signals during cardiopulmonary bypass surgery. Stroke 1997; 28:1988-1992.
39. Brener BJ, Brief DK, Alpert J, Goldenkranz RJ, Paronnet V. The risk of stroke in patients with asymptomatic carotid stenosis undergoing cardiac surgery. J Vasc Surg 1987, 5:269-277.
40. Change BB, Darling RC 3rd, Shah DM, Paty PS, Leather RP. Carotid endarterectomy can be safely performed with acceptable mortality and morbidity in patients requiring coronary artery bypass graft. Am J Surg 1994; 168:94-96.
41. Kaul TK, Fields BL, Wyatt DA, Jones CR, Kahn DR. Surgical management in patients with coexistent coronary and cerebrovascular disease Long term results. Chest 1994; 106:1349-1357.
42. Giangola G, Migaly J, Riles TS, Lamparello PJ, Adelman MA, Grossi E, et al. Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. Annals of Vasc Surg 1996; 10:138-142. A retrospective study of 57 patients who underwent CABG and CEA (28 simultaneous CABG and CEA, 17 CEA before CABG and 12 CABG before CEA). The results showed that the simultaneous procedure was associated with increased neurologic morbidity. Among the patients with staged procedure, those in whom CABG preceded CEA fared better in terms of decreased cardiac and neurologic morbidity.
43. Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin N Am 1992; 10:167-176.
44. Oppenheimer SM, Wilson JX, Guiraudon C, Cechetto DF. Insular cortex stimulation produces lethal cardiac arrhythmias: a mechanism of sudden death? Brain Res 1991; 550:115-121.
45. Kulshreschtha N, Zhang ZII, Oppenheimer SM. Effects of insular lesions on the rat baroreceptor reflex. Soc Neurosci Abstracts 1996, 22:157.